DK1564290T3 - Fremgangsmåde til identifikation af nucleinsyreligander i målvæv - Google Patents
Fremgangsmåde til identifikation af nucleinsyreligander i målvævInfo
- Publication number
- DK1564290T3 DK1564290T3 DK04015822T DK04015822T DK1564290T3 DK 1564290 T3 DK1564290 T3 DK 1564290T3 DK 04015822 T DK04015822 T DK 04015822T DK 04015822 T DK04015822 T DK 04015822T DK 1564290 T3 DK1564290 T3 DK 1564290T3
- Authority
- DK
- Denmark
- Prior art keywords
- nucleic acid
- acid ligands
- cells
- ligands
- target tissues
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6811—Selection methods for production or design of target specific oligonucleotides or binding molecules
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/111—General methods applicable to biologically active non-coding nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/115—Aptamers, i.e. nucleic acids binding a target molecule specifically and with high affinity without hybridising therewith ; Nucleic acids binding to non-nucleic acids, e.g. aptamers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/16—Aptamers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/32—Chemical structure of the sugar
- C12N2310/322—2'-R Modification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/35—Nature of the modification
- C12N2310/351—Conjugate
- C12N2310/3517—Marker; Tag
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2320/00—Applications; Uses
- C12N2320/10—Applications; Uses in screening processes
- C12N2320/13—Applications; Uses in screening processes in a process of directed evolution, e.g. SELEX, acquiring a new function
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
- G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
- G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
- G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
- G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
- G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
- G01N2333/96433—Serine endopeptidases (3.4.21)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Plant Pathology (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/433,124 US5750342A (en) | 1990-06-11 | 1995-05-03 | Nucleic acid ligands of tissue target |
| US08/433,126 US5688935A (en) | 1990-06-11 | 1995-05-03 | Nucleic acid ligands of tissue target |
| PCT/US1996/006059 WO1996034874A1 (en) | 1995-05-03 | 1996-05-01 | Nucleic acid ligands of tissue target |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1564290T3 true DK1564290T3 (da) | 2008-11-17 |
Family
ID=27029755
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK04015822T DK1564290T3 (da) | 1995-05-03 | 1996-05-01 | Fremgangsmåde til identifikation af nucleinsyreligander i målvæv |
Country Status (9)
| Country | Link |
|---|---|
| EP (3) | EP2000534A3 (es) |
| JP (1) | JPH11504812A (es) |
| AT (2) | ATE276266T1 (es) |
| AU (1) | AU727460B2 (es) |
| CA (2) | CA2641149A1 (es) |
| DE (2) | DE69637605D1 (es) |
| DK (1) | DK1564290T3 (es) |
| ES (1) | ES2310695T3 (es) |
| WO (1) | WO1996034874A1 (es) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6127119A (en) * | 1990-06-11 | 2000-10-03 | Nexstar Pharmaceuticals, Inc. | Nucleic acid ligands of tissue target |
| US6346611B1 (en) * | 1990-06-11 | 2002-02-12 | Gilead Sciences, Inc. | High affinity TGfβ nucleic acid ligands and inhibitors |
| US6716580B2 (en) | 1990-06-11 | 2004-04-06 | Somalogic, Inc. | Method for the automated generation of nucleic acid ligands |
| US6068829A (en) | 1995-09-11 | 2000-05-30 | The Burnham Institute | Method of identifying molecules that home to a selected organ in vivo |
| US20070166741A1 (en) | 1998-12-14 | 2007-07-19 | Somalogic, Incorporated | Multiplexed analyses of test samples |
| US6232287B1 (en) | 1998-03-13 | 2001-05-15 | The Burnham Institute | Molecules that home to various selected organs or tissues |
| MXPA01007352A (es) * | 1999-01-19 | 2003-06-06 | Somalogic Inc | Metodo y aparato para la generacion automatizada de ligandos de acido nucleico. |
| US7420030B2 (en) | 2000-09-08 | 2008-09-02 | The Board Of Regents Of The University Of Texas System | Aminopeptidase A (APA) targeting peptides for the treatment of cancer |
| US20040170955A1 (en) | 2000-09-08 | 2004-09-02 | Wadih Arap | Human and mouse targeting peptides identified by phage display |
| US7452964B2 (en) | 2001-09-07 | 2008-11-18 | Board Of Regents, The University Of Texas System | Compositions and methods of use of targeting peptides against placenta and adipose tissues |
| US8030465B2 (en) | 2001-06-29 | 2011-10-04 | Medimolecular Pty Ltd | Nucleic acid ligands to complex targets |
| AU2775402A (en) * | 2001-06-29 | 2003-01-02 | Medimolecular Pty Ltd | Nucleic acid ligands to complex targets |
| US7855054B2 (en) | 2007-01-16 | 2010-12-21 | Somalogic, Inc. | Multiplexed analyses of test samples |
| US20110136099A1 (en) | 2007-01-16 | 2011-06-09 | Somalogic, Inc. | Multiplexed Analyses of Test Samples |
| US8906700B2 (en) | 2007-11-06 | 2014-12-09 | Ambergen, Inc. | Methods and compositions for phototransfer |
| EP2078751A1 (en) * | 2008-01-11 | 2009-07-15 | Commissariat A L'energie Atomique | Specific aptamers generated for suppression of cell migration and invasion by cancer cells, methods of selection for such aptamers and their usage |
| EP2159286A1 (en) * | 2008-09-01 | 2010-03-03 | Consiglio Nazionale Delle Ricerche | Method for obtaining oligonucleotide aptamers and uses thereof |
| RU2732402C2 (ru) | 2013-11-21 | 2020-09-16 | Сомалоджик, Инк. | Цитидин-5-карбоксамид модифицированные нуклеотидные композиции и способы, относящиеся к ним |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5705337A (en) | 1990-06-11 | 1998-01-06 | Nexstar Pharmaceuticals, Inc. | Systematic evolution of ligands by exponential enrichment: chemi-SELEX |
| US5683867A (en) | 1990-06-11 | 1997-11-04 | Nexstar Pharmaceuticals, Inc. | Systematic evolution of ligands by exponential enrichment: blended SELEX |
| US5637459A (en) | 1990-06-11 | 1997-06-10 | Nexstar Pharmaceuticals, Inc. | Systematic evolution of ligands by exponential enrichment: chimeric selex |
| US5270163A (en) | 1990-06-11 | 1993-12-14 | University Research Corporation | Methods for identifying nucleic acid ligands |
| KR970002255B1 (ko) | 1990-06-11 | 1997-02-26 | 넥스스타 파아마슈티컬드, 인크. | 핵산 리간드 |
| US5496938A (en) | 1990-06-11 | 1996-03-05 | Nexstar Pharmaceuticals, Inc. | Nucleic acid ligands to HIV-RT and HIV-1 rev |
| WO1992014842A1 (en) * | 1991-02-21 | 1992-09-03 | Gilead Sciences, Inc. | Aptamers specific for thrombin and methods of use |
| IE920562A1 (en) * | 1991-02-21 | 1992-08-26 | Gilead Sciences | Aptamer specific for biomolecules and method of making |
| US5726014A (en) * | 1991-06-27 | 1998-03-10 | Genelabs Technologies, Inc. | Screening assay for the detection of DNA-binding molecules |
| AU7102594A (en) * | 1993-06-09 | 1995-01-03 | Pharmagenics, Inc. | Oligonucleotides which inhibit hiv protease function |
| ATE274520T1 (de) * | 1995-05-03 | 2004-09-15 | Gilead Sciences Inc | Systematische evoultion von liganden durch exponentielle anreicherung: gewebe-selex |
| US20170110787A1 (en) | 2015-10-14 | 2017-04-20 | Apple Inc. | Electronic Devices With Millimeter Wave Antennas And Metal Housings |
-
1996
- 1996-05-01 CA CA002641149A patent/CA2641149A1/en not_active Abandoned
- 1996-05-01 JP JP8533450A patent/JPH11504812A/ja not_active Ceased
- 1996-05-01 ES ES04015822T patent/ES2310695T3/es not_active Expired - Lifetime
- 1996-05-01 AT AT96915422T patent/ATE276266T1/de not_active IP Right Cessation
- 1996-05-01 EP EP08012656A patent/EP2000534A3/en not_active Withdrawn
- 1996-05-01 AU AU57200/96A patent/AU727460B2/en not_active Expired
- 1996-05-01 DE DE69637605T patent/DE69637605D1/de not_active Expired - Lifetime
- 1996-05-01 EP EP04015822A patent/EP1564290B1/en not_active Expired - Lifetime
- 1996-05-01 CA CA002219106A patent/CA2219106C/en not_active Expired - Lifetime
- 1996-05-01 DE DE69633386T patent/DE69633386T2/de not_active Expired - Lifetime
- 1996-05-01 WO PCT/US1996/006059 patent/WO1996034874A1/en active IP Right Grant
- 1996-05-01 AT AT04015822T patent/ATE401424T1/de not_active IP Right Cessation
- 1996-05-01 DK DK04015822T patent/DK1564290T3/da active
- 1996-05-01 EP EP96915422A patent/EP0824540B1/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| CA2219106A1 (en) | 1996-11-07 |
| EP1564290B1 (en) | 2008-07-16 |
| AU5720096A (en) | 1996-11-21 |
| DE69633386D1 (de) | 2004-10-21 |
| ES2310695T3 (es) | 2009-01-16 |
| ATE276266T1 (de) | 2004-10-15 |
| DE69637605D1 (de) | 2008-08-28 |
| JPH11504812A (ja) | 1999-05-11 |
| EP0824540B1 (en) | 2004-09-15 |
| EP1564290A3 (en) | 2006-02-01 |
| AU727460B2 (en) | 2000-12-14 |
| CA2219106C (en) | 2008-09-23 |
| EP1564290A2 (en) | 2005-08-17 |
| EP2000534A3 (en) | 2009-09-02 |
| EP2000534A2 (en) | 2008-12-10 |
| EP0824540A4 (en) | 2003-04-23 |
| WO1996034874A1 (en) | 1996-11-07 |
| CA2641149A1 (en) | 1996-11-07 |
| DE69633386T2 (de) | 2005-09-22 |
| ATE401424T1 (de) | 2008-08-15 |
| EP0824540A1 (en) | 1998-02-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1564290T3 (da) | Fremgangsmåde til identifikation af nucleinsyreligander i målvæv | |
| CA2219807A1 (en) | Systematic evolution of ligands by exponential enrichment: tissue selex | |
| DE69434942D1 (de) | Mehrzweckreagenzsystem zur schnellen lysierung von vollblutproben | |
| DE69915932D1 (de) | Verfahren zur Bestimmung von Ziel-Nukleinsäuren | |
| MX9100052A (es) | Biblioteca(o conjunto)de bio-oligomeros al azar,un metodo de sintesis de los mismos y un metodo de uso de los mismos | |
| DE69132098D1 (de) | Verfahren zur amplifikation von nukleinsäuren | |
| DE69128362D1 (de) | Zusammensetzungen und verfahren zur identifizierung von molekülen mit biologischer wirksamkeit | |
| ATE266723T1 (de) | Lösung die chaotropische mittel enthält und verwendung dieser lösung in verfahren zur isolierung von dna, rna und proteinen | |
| DE69626832D1 (de) | Blutbehandlungssysteme und methoden zur gewinnung von mononuklearen zellen | |
| ID28971A (id) | Turunan 2-ureido-tiazol, proses pembuatannya, dan penggunaannya sebagai zat anti tumor | |
| DE69834809D1 (de) | Verfahren zur gewinnung von seltenen zellen aus blutprodukten | |
| DE69822348D1 (de) | R. b. yun s verfahren zur ausbeutung von tagebaulagerstätten | |
| WO1996034113A3 (en) | Methods for the identification of farnesyltransferase inhibitors | |
| DE69815370D1 (de) | Fluoreszend-konjugaten von nukleosiden und von nukleotiden, ihrer verfahren zur herstellung und ihrer verwendungen | |
| DE69604990T2 (de) | Verfahren zur Erhöhung der Katalysatorwirksamkeit bei der Redistribution von Polycarbonat | |
| DE59712415D1 (de) | Verfahren zur amplifikation von nukleinsäure | |
| DE69428278T2 (de) | Leukozytadhaesiontest | |
| DE69508633T2 (de) | Verfahren zur stufenweise Pfropfung von Olefinpolymeren und daraus hergestellte Pfropfpolymerisate | |
| DE69807148D1 (de) | Verfahren zur Hydroformylierung von Olefininen | |
| ATE293121T1 (de) | Verfahren zur kombination von paralleler oligonukleotidsynthese und darstellung von oligomer-chips | |
| DE68920659D1 (de) | Nukleosidoxidase und analytisches verfahren. | |
| DE69023710D1 (de) | Verfahren zur bestimmung von enzymatischer wirksamkeit. | |
| DE59009410D1 (de) | Verfahren zum passiven Bestimmen von Zieldaten. | |
| ATE105871T1 (de) | Verfahren zur stabilisierung der hybridisierung von komplementären polynukleotidsequenzen. | |
| WO2003048783A3 (en) | Monocyte adhesion |